Vı́ctor Segarra

Synthesis and Biological Evaluation of 3,4-Diaryloxazolones:  A New Class of Orally Active Cyclooxygenase-2 Inhibitors

Carles Puig, M. Crespo, Núria Godessart et al. · Journal of Medicinal Chemistry · 1999 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Novel Heterocyclic-Fused Pyridazinones as Potent and Selective Phosphodiesterase IV Inhibitors

Vittorio Dal Piaz, Maria Paola Giovannoni, Carla Castellana et al. · Journal of Medicinal Chemistry · 1997 · 72 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Discovery of Novel Quaternary Ammonium Derivatives of (3<i>R</i>)-Quinuclidinol Esters as Potent and Long-Acting Muscarinic Antagonists with Potential for Minimal Systemic Exposure after Inhaled Administration: Identification of (3<i>R</i>)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane Bromide (Aclidinium Bromide)

María Prat, Dolors Fernández, María Antonia Buil et al. · Journal of Medicinal Chemistry · 2009 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Benzyl Derivatives of 2,1,3-Benzo- and Benzothieno[3,2-<i>a</i>]thiadiazine 2,2-Dioxides:  First Phosphodiesterase 7 Inhibitors

Ana Martı́nez, Ana Castro, Carmen Gil et al. · Journal of Medicinal Chemistry · 2000 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Phosphodiesterase inhibitory properties of losartan. design and synthesis of new lead compounds

Vı́ctor Segarra, Maribel Crespo, Ferran Pujol et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14